Christophe Van Dijck

Christophe Van Dijck is a Researcher at the Institute of Tropical Medicine Antwerp, specializing in Emerging Infectious Diseases and Antimicrobial Resistance. He leads projects on mpox outbreaks in Central Africa, gonococcal resistance mechanisms, and STI epidemiology. His work integrates clinical, microbiological, and public health perspectives to address global health challenges. Recent projects include 'Mpox, a tale of two epidemics' and 'Resistance in gonorrhoea,' involving collaborations across multiple institutions.

His research focuses on viral and bacterial pathogens, particularly Neisseria species and mpox virus. Key areas include antimicrobial resistance patterns, outbreak investigation, and vaccine efficacy assessment. He has published extensively in high-impact journals like The Lancet and Clinical Microbiology and Infection.

Van Dijck collaborates with global networks in the Democratic Republic of the Congo, Cameroon, and Belgium. His work emphasizes One Health approaches, linking human, animal, and environmental health. He advises on public health strategies to mitigate antimicrobial resistance and control emerging infections.